1 year return (CAGR)
-52.56%
Annovis Bio Inc Exchange (NYSE, USD)
ANVS
1.09
+0.02 (+2.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-49.54%
5 year return (CAGR)
-49.02%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
43.53M
Price/Sales
-
Ent value
51.10M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
10.15%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.98 |
| Daily high | 1.03 |
| Daily low | 0.98 |
| Daily Volume | 911K |
| All-time high | 120.97 |
| 1y analyst estimate | 10.50 |
| Beta | 1.24 |
| EPS (TTM) | -1.32 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 23 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ANVS | S&P500 | |
| Current price drop from All-time high | -99.10% | -3.18% |
| Highest price drop | -99.21% | -56.47% |
| Date of highest drop | 26 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -77.02% | -10.65% |
| Avg time to new high | 41 days | 12 days |
| Max time to new high | 1331 days | 1805 days |
News
